Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  receptor tyrosine kinase inhibitor XL647
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: KD019-204, NCI-2014-02048, NCT02154529
Start Over